
Hadasit Bio-Holdings serves as a precedent in biotech financing - for the first time, public investment is allowed to participate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").
Read more ↓
Tired of ads? Enjoy an ad-free experience by signing up.
Review
By reading these reviews and ratings, you agree to Tech in Asia’s terms of use.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:





Similar investors






Tired of ads? Enjoy an ad-free experience by signing up.